Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: An international survey of current clinical practice

Italian Heart Journal

Volumn 5, Issue 11, 2004, Pages 851-856

  Rubboli, Andrea ^a   Colletta, Mauro ^a   Sangiorgio, Pietro ^a   di Pasquale, Giuseppe ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Antiaggregating agents; Anticoagulants; Coronary angioplasty; Stenting

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; FIBRINOLYTIC THERAPY; HUMAN; PRACTICE GUIDELINE; QUESTIONNAIRE; STATISTICS; STENT;

ANTICOAGULANTS; CORONARY DISEASE; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; STENTS; THROMBOLYTIC THERAPY;

EID: 14844294763     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.
2. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-71.
3. Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). Circulation 1998; 98: 2126-32.
4. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) Study. Circulation 1998; 98: 1597-603.
5. Cosmi B, Rubboli A, Castelvetri C, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database Syst Rev 2001; (4): CD002133.
6. Casella G, Ottani F, Pavesi PC, et al. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis. Ital Heart J 2003; 4: 677-84.
7. Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998; 129: 394-405.
8. Little SH, Massel DR. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev 2003; (4): CD003464.
9. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001; 119 (Suppl): 220S-227S.
10. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119 (Suppl): 194S-206S.
11. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
12. ESPRIT. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage. Stroke 2003; 34: E45-E46.
13. Orford JL, Fasseas P, Melby S, et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004; 147: 463-7.
14. van den Besselaar AM, van der Meer FJ, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-90.
15. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands. Arch Intern Med 2003; 163: 2639-46.
16. Torn M, van der Meer FJ, Rosendaal FR. Lowering the intensity of oral anticoagulant therapy. Effects on the risk of hemorrhage and thromboembolism. Arch Intern Med 2004; 164: 668-73.
17. Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987; 44: 430-45.
18. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-26.
19. Batchelor WB, Mahaffey KW, Berger PB, et al. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol 2001; 38: 1608-13.
20. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-98.
21. Brouwer MA, Verheugt FW. Oral anticoagulation for acute coronary syndromes. Circulation 2002; 105: 1270-4.
22. Anand SS, Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol 2003; 41 (Suppl S): 62S-69S.
23. Spencer FA, Becker RC. When guidelines collide... Am Heart J 2004; 147: 395-7.